{
    "2021-07-15": [
        [
            {
                "time": "2023-10-10",
                "original_text": "Incyte's Ruxolitinib Shows Better Outcomes Regardless Of Organs Affected In GvHD Patients",
                "features": {
                    "keywords": [
                        "Incyte",
                        "Ruxolitinib",
                        "Better Outcomes",
                        "GvHD",
                        "Patients"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}